advertisement
11.3.4 Betablocker (9)
Showing records 1 to 9
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker20356 Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction
Seider N; Miller B; Beiran I
American Journal of Ophthalmology 2008; 145: 120-123
20366 Effects of timolol on MYOC, OPTN, and WDR36 RNA levels
Rozsa FW; Scott K; Pawar H; Moroi S; Richards JE
Archives of Ophthalmology 2008; 126: 86-93
20547 Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods and Findings in Experimental and Clinical Pharmacology 2007; 29: 665-671
20405 Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma
Costagliola C; Parmeggiani F; Virgili G; Lamberti G; Incorvaia C; Perri P; Campa C; Sebastiani A
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 389-396
20337 Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis
Kamiya K; Aizawa D; Igarashi A; Komatsu M; Shimizu K
American Journal of Ophthalmology 2008; 145: 233-238
20603 Drug induced asthma
Kostoudi S; Mironidou-Tzouveleki M
Epitheorese Klinikes Farmakologias kai Farmakokinetikes 2007; 25: 163-174
20834 Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course
Izzotti A; Saccà SC; Di Marco B; Penco S; Bassi AM
Eye 2008; 22: 445-453
20841 Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy
Cai JP; Cheng JW; Wei RL; Ma XY; Jiang F; Zhu H; Li Y
International Ophthalmology 2008; 28: 19-22
20768 Open-angle Glaucoma and Mortality: The Barbados Eye Studies
Wu SY; Nemesure B; Hennis A; Schachat AP; Hyman L; Leske MC; for the Barbados Eye Studies Group
Archives of Ophthalmology 2008; 126: 365-370
